SIDEROS: A Phase III Double-BLind, Randomized, Placebo-controlled Study Assessing the efficacy, safety and...
Project Description:
Santhera Pharmaceuticals (Switzerland)
SIDEROS: A Phase III Double-BLind, Randomized, Placebo-controlled Study Assessing the efficacy, safety and Tolerability of Idebenone in Patients with DMD Receiving Glucocorticoid Steroids.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
International
COVID-19 Related Data:
N/A